Price
No data yet.
Social Signal Score
Analyst Ratings
3 analystsRevenue
$265.81M+171.71%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Matthijs Glastra
- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- Employees
- 3,000
- Beta
- 1.68
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 7.45
Financials
Revenue
$265.81M+171.7%Net Income
$12.54M+67.9%EBITDA
$17.00M+10.6%Free Cash Flow
$58.76M+538.8%EPS (diluted)
$0.30+42.9%Shares Outstanding (diluted)
41.16M+17.9%Operating Expenses
$83.94MCash & Debt
$718.65MReturn of Capital
$0.00Revenue by Segment (annual)
$980.60MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $980.60M | $53.83M | $1.47 |
| 2024 | $949.25M | $64.09M | $1.78 |
| 2023 | $881.66M | $72.88M | $2.03 |
| 2022 | $860.90M | $74.05M | $2.08 |
| 2021 | $706.79M | $50.33M | $1.42 |
| 2020 | $590.62M | $44.52M | $1.27 |
| 2019 | $626.10M | $40.77M | $1.16 |
| 2018 | $614.34M | $49.11M | $1.46 |
| 2017 | $521.29M | $60.05M | $1.14 |
| 2016 | $384.76M | $22.00M | $0.63 |
| 2015 | $373.60M | $35.62M | $1.03 |
| 2014 | $364.71M | $-24.25M | $-0.70 |
| 2013 | $341.61M | $7.31M | $0.21 |
| 2012 | $271.50M | $19.54M | $0.58 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from NOVT's reported EPS growth of 7.4% a year over 13 years.
- EPS in 5 years
- $2.10
- Implied price
- $37.84
- Return from $149.27
- -24.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $18.81 — -87.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -2.6% | -36.4% | -33.5% | -31.1% | -28.9% | -27.0% |
| 2.4% | -33.2% | -30.1% | -27.5% | -25.3% | -23.2% |
| 7.4% | -29.9% | -26.7% | -24.0% | -21.6% | -19.5% |
| 12.4% | -26.7% | -23.3% | -20.5% | -18.0% | -15.8% |
| 17.4% | -23.4% | -19.9% | -16.9% | -14.3% | -12.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
30+0.00%Social Signal Score
Mentions (8)
- Newsetftrends.com·19d ago·Negative
How to Build a Humanoid Body Last month we broke down the three key areas needed to build your own humanoid. We have already looked at the companies behind the technologies required to build a humanoid's brain.
View source ↗ - News (RSS)financialpost·38d ago·Neutral
Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026 BOSTON — Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. […]
View source ↗ - Newsbusinesswire.com·38d ago·Neutral
Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026 BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novant…
View source ↗ - News (RSS)seekingalpha·44d ago·Positive
Novanta: A Strong Year So Far, Fully Priced In
View source ↗ - News (Marketaux)seekingalpha.com·44d ago·Positive
Novanta: A Strong Year So Far, Fully Priced In (NASDAQ:NOVT) Novanta: A Strong Year So Far, Fully Priced In (NASDAQ:NOVT)
View source ↗ - Newszacks.com·49d ago·Positive
Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
View source ↗ - Newszacks.com·54d ago·Neutral
Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - 4chan /biz/biz·56d ago·Negative
>>62579859 kek it’s really hard to see one of your closest allies shooting themselves in the foot, knowing you’ll be blamed for it a month later… >>62579347 yeah we’ll play find 10 differences between sand monkeys later today, thanks for the great idea idk I’ve purposely been avoiding tech this past year like a chick with stds but NOVT and MOG-A look pretty solid and actuators make up for 50+% of the current robotics costs. Anyone knows any good EU defence contractors? Would be really nice know
View source ↗
Earnings
Mon, Nov 2(in 4 weeks)
Consensus estimate $0.97 per share
Typical surprise +3.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$0.89 vs $0.83beat
- Mon, May 11$0.81 vs $0.78beat
- Mon, Feb 23$0.91 vs $0.88beat
- Mon, Nov 3$0.87 vs $0.81beat
- Tue, Aug 5$0.76 vs $0.74beat
- Tue, May 6$0.74 vs $0.68beat
Estimates and results for NOVT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NOVT officers and directors.
- Bought
- —
- Sold
- $11.3m
0 trades
42 trades
- Secor Thomas Nsold
- Glastra Matthijssold
- Glastra Matthijssold
- Glastra Matthijssold
- Glastra Matthijssold
- Glastra Matthijssold
- Glastra Matthijssold
- Glastra Matthijssold
58 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Gilbert Ray Cisneroshouse · CA31 · disclosed Jun 9, 2026 (22d later)Buy$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Dec 15, 2025 (32d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (22d later)Buy$1,001 - $15,000
- Josh S. Gottheimerhouse · NJ05 · disclosed Aug 29, 2022 (35d later)Sell$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA39 · disclosed Nov 15, 2019 (24d later)Buy$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA39 · disclosed Aug 19, 2019 (18d later)Buy$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA39 · disclosed Jun 18, 2019 (27d later)Buy$1,001 - $15,000
- Josh S. Gottheimerhouse · NJ05 · disclosed May 20, 2019 (35d later)Buy$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA39 · disclosed May 14, 2019 (27d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.